148 / 150
Guía OncoSur de diagnóstico y tratamiento del dolor
148
>
BIBLIOGRAFÍA RECOMENDADA
Amabile CM, Bowman BJ. Overview of oral modified-release opioid products for the management of chronic pain.
Ann Pharmacother. 2006;40:1327-35.
Bajwa Z, Warfield C. Cancer pain syndromes. [Monografía en Internet]. Walthman (MA): Uptodate; 2008; [acceso
14 Ene 2009]. Disponible en:
http://www.uptodate.comCasals Merchán M, Mayoral Rojals V. Manual control de síntomas en pacientes con cáncer avanzado terminal: Me-
didas intervencionistas. 3.ª ed. Madrid: Arán Ediciones; 2013. p. 101-10.
Davies A, Dickman A, Reid C, et al. The management of cancer-related breakthrouh pain: Recommendations of a
task group of the Science Committee of the Association for Palliative Medicine of Grat Britain and Ireland. Euro-
pean Journal of Pain. 2009;13:331-8.
Finnerup algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118(3):289-305.
Grossman SA, Nesbit S. Cancer related pain. En: Niederhuber Jhon E, eds. Abeloff’s clinical oncology. Philadelphia:
Elsevier Churchill Livingstone; 2014. p. 608-19.
Jost L, Roila F. Management of cancer pain: ESMO Clinical Recommendations. Annals of Oncology 2008;19(Suppl
2):119-21.
Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and
dexamethasone on human pituitary-adrenal function. Am J of Med. 1977;63:200-7.
Porta Sales J, Gómez Batiste X, Tuca Rodríguez A. Manual control de síntomas en pacientes con cáncer avanzado y
terminal. 3ª ed. ICO. Barcelona: Arán Ediciones; 2004.
Rauck RL. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic
pain? A critical review. Pain Pract. 2009;9:468-79.
Rodrigo M, Herrera J, Busquets C, et al. Intercambiabilidad de opioides y moléculas bioequivalentes. Revista de la
Sociedad Española del Dolor. 2010;17:104.
Wallace MS. Treatment opions for refracoy pain. The role of intrathecal therap. Neurology. 2002;59 (Suppl 2):18-24.